Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors

Novel treatments based upon the use of immune checkpoint inhibitors have an impressive efficacy in different types of cancer. Unfortunately, most patients do not derive benefit or lasting responses, and the reasons for the lack of therapeutic success are not known. Over the past two decades, a press...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibellini, Lara, De Biasi, Sara, Porta, Camillo, Lo Tartaro, Domenico, Depenni, Roberta, Pellacani, Giovanni, Sabbatini, Roberto, Cossarizza, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100547/
https://www.ncbi.nlm.nih.gov/pubmed/32265933
http://dx.doi.org/10.3389/fimmu.2020.00490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100547/
https://www.ncbi.nlm.nih.gov/pubmed/32265933
http://dx.doi.org/10.3389/fimmu.2020.00490

Ejemplares similares